Expert Video - Are clinical trials an option in treatment failure or relapse in AML?

Dr. Barry Skikne, an expert on acute myeloid leukemia (AML), discusses clinical trials for treatment failure or relapse in AML. Whenever possible, it is important to join a clinical trial for a new AML treatment. The knowledge gained helps to advance treatment for persons with AML. Dr Skikne explains the various benefits of participating in clinical trials, how they work, and what to expect. It is important to discuss all your treatment options, including clinical trials, with your doctor or cancer care team.

  • Share with family and friends:

Click here to take our SURVEY
Your feedback is important to us! We will use your feedback to develop future areas of content about AML which will help other patients, caregivers and families.

This educational activity has been developed by the Myelodysplastic Syndromes Foundation, Inc. and Mechanisms in Medicine Inc.

This activity is supported by educational grants from AbbVie, Acceleron, Bristol-Myers Squibb, Celgene Corporation, Daiichi Sankyo, Jazz Pharmaceuticals and Takeda Oncology.

This website is part of the Animated Patient™ series developed by Mechanisms in Medicine Inc., to provide highly visual formats of learning for patients to improve their understanding, make informed decisions, and partner with their healthcare professionals for optimal outcomes.